Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDK2 | Q15119 | 1/20 | 0.37 |
| ▸ | AKR1A1 | P14550 | 1/20 | 0.33 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.33 |
| ▸ | S100A4 | P26447 | 1/20 | 0.32 |
| ▸ | BACE1 | P56817 | 3/20 | 0.32 |
| ▸ | CTSD | P07339 | 1/20 | 0.32 |
| ▸ | HTR2B | P41595 | 1/20 | 0.32 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.32 |
| ▸ | TDP2 | O95551 | 1/20 | 0.32 |
| ▸ | CA1 | P00915 | 1/20 | 0.32 |
| ▸ | CA2 | P00918 | 1/20 | 0.32 |
| ▸ | CA4 | P22748 | 1/20 | 0.32 |
| ▸ | CA7 | P43166 | 1/20 | 0.32 |
| ▸ | CA9 | Q16790 | 1/20 | 0.32 |
| ▸ | MALT1 | Q9UDY8 | 1/20 | 0.31 |
| ▸ | PGR | P06401 | 1/20 | 0.31 |
| ▸ | PTGES | O14684 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2484075 | 1.00 | PDK2 (0.37) | PDK2AKR1A1AKR1B1S100A4BACE1 | |
| SCHEMBL13995263 | 0.79 | PDK2 (0.38) | PDK2CA1CA2CA4CA7 | |
| SCHEMBL2487230 | 0.79 | PDK2 (0.40) | PDK2AKR1A1AKR1B1S100A4HTR2B | |
| SCHEMBL2487352 | 0.79 | PDK2 (0.40) | PDK2AKR1A1AKR1B1S100A4HTR2B | |
| SCHEMBL13995261 | 0.74 | PDK2 (0.37) | PDK2AKR1A1AKR1B1S100A4TDP2 | |
| SCHEMBL17430723 | 0.73 | PDK2 (0.44) | PDK2AKR1A1AKR1B1S100A4HTR2B | |
| SCHEMBL29403081 | 0.73 | PDK2 (0.44) | PDK2AKR1A1AKR1B1S100A4HTR2B | |
| SCHEMBL19116324 | 0.73 | PDK2 (0.44) | PDK2AKR1A1AKR1B1S100A4HTR2B | |
| SCHEMBL29587737 | 0.73 | PDK2 (0.44) | PDK2AKR1A1AKR1B1S100A4HTR2B | |
| SCHEMBL204806 | 0.73 | PDK2 (0.44) | PDK2AKR1A1AKR1B1S100A4HTR2B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1717258-B1 | DIHALIDE, POLYMER COMPOUND AND METHOD FOR PRODUCING SAME | TOKYO INST TECH (JP) | 2011-10-19 | — | — | EP | disclosed |
| US-7462683-B2 | Dihalide, polymer compound and method for producing the same | TOKYO INSTITUTE OF TECHNOLOGY (JP) | 2008-12-09 | — | — | US | disclosed |
| US-7462683-B2 | Dihalide, polymer compound and method for producing the same | TOKYO INSTITUTE OF TECHNOLOGY (JP) | 2008-12-09 | — | — | US | disclosed |
| US-20070185306-A1 | Dihalide, polymer compound and method for producing the same | TOKYO INSTITUTE OF TECHNOLOGY (JP) | 2007-08-09 | — | — | US | disclosed |
| US-20070185306-A1 | Dihalide, polymer compound and method for producing the same | TOKYO INSTITUTE OF TECHNOLOGY (JP) | 2007-08-09 | — | — | US | disclosed |
| EP-1717258-A1 | DIHALIDE, POLYMER COMPOUND AND METHOD FOR PRODUCING SAME | Tokyo Institute of Technology (JP) | 2006-11-02 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070185306-A1 | Dihalide, polymer compound and method for producing the same | HSPA4L, HDHD5, MRPL21 | PDK2 2058/4885AKR1A1 2065/4885AKR1B1 1804/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.